Banquisio, Rhianna S.
HRN: 22-75-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2023
CLOXACILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
03/22/2023
03/29/2023
ORAL
5 Ml
Q6h
Burns
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes